论文部分内容阅读
目的:为观察曲美他嗪治疗心力衰竭的疗效。方法:选择心力衰竭患者82例,分为两组,治疗组42例,常规治疗+曲美他嗪,对照组40例,仅用常规治疗。结果:治疗组总有效率为88.9%,对照组为65.0%,两组相比差异有统计学意义(P<0.05),其中冠心病心衰心功能的改善最为显著(总有效率为96.3%)。结论:曲美他嗪加常规方法治疗心力衰竭有利于心功能的改善,提示曲美他嗪是治疗心力衰竭的较好辅助药物。
Objective: To observe the efficacy of trimetazidine in the treatment of heart failure. Methods: 82 patients with heart failure were selected and divided into two groups. The treatment group was 42 cases, the routine treatment + trimetazidine, and the control group, 40 cases, only conventional treatment. Results: The total effective rate was 88.9% in the treatment group and 65.0% in the control group, with significant difference between the two groups (P <0.05). The improvement of heart function in the patients with coronary heart disease was the most significant (the total effective rate was 96.3% ). Conclusion: Trimetazidine combined with conventional treatment of heart failure is conducive to the improvement of cardiac function, suggesting that trimetazidine is a good adjunct to treat heart failure.